Clinical Trial Update: A Clinical Pharmacology Study of Saxagliptin in Patients With Type 2 Diabetes Mellitus [Phase 3]

View source ↗

Summary

A completed Phase 3 clinical pharmacology study evaluating saxagliptin in adults with Type 2 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Saxagliptin (saxagliptin)

Snippet

Sponsor: Kyowa Kirin Co., Ltd. | Conditions: Diabetes | Phase 3 | Status: COMPLETED